Administration of Methotrexate in Rheumatoid Arthritis Patients with Chronic Hepatitis B

Authors

  • Velma Herwanto Department of Internal Medicine, Faculty of Medicine, University of Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
  • Andri Sanityoso Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine University of Indonesia/Dr.Cipto Mangunkusumo General National Hospital, Jakarta

DOI:

https://doi.org/10.24871/161201557-63

Keywords:

methotrexate, chronic hepatitis B, antiviral prophylaxis

Abstract

Aim: To identify if methotrexate (MTX) may be given to chronic hepatitis B patients and to evaluate the necessity of antiviral prophylaxis administration.

Method: Literature search procedure to answer this clinical problem was performed by exploring the literature online using PubMed, Highwire Stanford University, NUS Library, and MD Consult search engines. With this searching method, we found 20 articles in English. From those 20 articles, there were two articles relevant based on the title and abstract (studies by Tamori et al and Mori).

Results: From 45 patients without HbsAg from Tamori et al study, only one from 3 patients receiving disease-modifying antirheumatoid drug/DMARD (including MTX) experienced reactivation. Those three patients did not receive anti-TNF-α therapy. Study by Mori concluded that DMARD was relatively safe to be given to most RA patients with the history of HBV infection, although they were not given anti HBV prophylaxis therapy.

Conclusion: MTX is not recommended for patient in this case because it is contraindicated to be given in HBV infected patient with any given Child Pugh score. If MTX is still given, it is recommended to give antiviral prophylaxis therapy.

 

Downloads

Published

2015-04-01

How to Cite

Herwanto, V., & Sanityoso, A. (2015). Administration of Methotrexate in Rheumatoid Arthritis Patients with Chronic Hepatitis B. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 16(1), 57–63. https://doi.org/10.24871/161201557-63

Issue

Vol. 16 No. 1 (2015): VOLUME 16, NUMBER 1, April 2015

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).